Welltower Inc. (WELL) Bundle
Jefferies Upgrades Welltower Inc. to Buy with $231 Price Target
Jefferies upgraded Welltower Inc. (NYSE:WELL) to a Buy rating on December 15, 2025. The financial firm raised its price target for the healthcare real estate investment trust to $231 from $210. At the time of the announcement, the stock was priced at $190.46.
Welltower's stock has appreciated 48.1% year-to-date, significantly exceeding the healthcare REIT industry average gain of 5.2%. This growth is supported by demand in the seniors housing operating portfolio and favorable trends in outpatient medical visits. Strategic portfolio restructuring and asset recycling have contributed to increased investor confidence and cash flow projections.
The company maintains a strong capital position to support its healthcare infrastructure specialize. Key financial and market metrics include:
- Market Capitalization: Approximately $130.72 billion
- Liquidity: $11.9 billion
- 52-Week Range: $123.11 to $209.05
- Daily Trading Volume: 3,061,872 shares
- Intraday Price Range: $187.83 to $190.95
The seniors housing operating portfolio is expected to experience robust demand driven by an aging population. Additionally, the outpatient medical segment is positioned to benefit from shifting healthcare delivery models. Welltower operates properties across the United States, Canada, and the United Kingdom, focusing on strategic buyouts to enhance its market presence.
For further information on the company's strategic direction, refer to the WELL-mission-vision and WELL-history-mission-ownership reports. Detailed analysis is also available regarding WELL-financial-health and the WELL-investor-profile, alongside the latest data on Welltower's stock performance.
Welltower Inc. (WELL) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.